Related Experiment Videos
Study on aneuploidy and p53 mutations in astrocytomas
P Campomenosi1, L Ottaggio, F Moro
1CSTA-Mutagenesis Laboratory, National Institute for Cancer Research (IST) Genova, Italy.
Cancer Genetics and Cytogenetics
|June 1, 1996
Summary
Aneuploidy (abnormal chromosome number) is common in astrocytomas, often occurring early. While p53 mutations predict poor prognosis, they don't strongly correlate with aneuploidy in these brain tumors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Astrocytic tumors are a type of brain cancer.
- The p53 gene plays a crucial role in tumor suppression.
- Aneuploidy, an abnormal chromosome number, is frequently observed in cancer.
Purpose of the Study:
- To investigate the relationship between p53 gene mutations and aneuploidy of chromosomes 10 and 17 in astrocytic tumors.
- To determine if these genetic alterations correlate with tumor grade and patient prognosis.
Main Methods:
- Analysis of 48 astrocytomas of varying malignancy grades.
- Polymerase chain reaction (PCR)-based denaturing gradient gel electrophoresis (DGGE) for p53 mutation detection (exons 5-8).
- Fluorescence in situ hybridization (FISH) for aneuploidy assessment of chromosomes 10 and 17.
Main Results:
- Aneuploidy of chromosomes 10 and 17 is a frequent early event in astrocytomas, present in 90% of low-grade tumors.
- p53 mutations and chromosome 17 aneuploidy occur early but are not grade-dependent.
- Loss of chromosome 10 significantly correlates with tumor progression.
- No significant correlation was found between p53 mutations and chromosome 10/17 aneuploidy, though they coexisted in some cases.
- p53 mutations were a significant predictor of poor prognosis.
Conclusions:
- Genomic instability in astrocytomas may arise independently of p53 mutations.
- Other cellular factors likely contribute to the observed aneuploidy.
- p53 mutation status is a critical prognostic indicator in astrocytic tumors.